Literature DB >> 23430124

Chronic effects of mild hyperglycaemia on left ventricle transcriptional profile and structural remodelling in the spontaneously type 2 diabetic Goto-Kakizaki rat.

Alicia D'Souza1, Frank C Howarth, Joseph Yanni, Halina Dobrzynski, Mark R Boyett, Ernest Adeghate, Keshore R Bidasee, Jaipaul Singh.   

Abstract

Heart failure in chronic type 2 diabetes mellitus is partly attributable to adverse structural remodelling of the left ventricle (LV), but the contribution of hyperglycaemia (HG) per se in remodelling processes is debated. In this study, we examined the molecular signature of LV remodelling in 18-month-old spontaneously diabetic male Goto-Kakizaki (GK) rats that represent a long-term mildly diabetic phenotype, using histological, immunoblotting and quantitative gene expression approaches. Relative to age-matched Wistar controls, mildly diabetic GK rats presented with LV hypertrophy, increased expression of natriuretic peptides and phosphorylation of pro-hypertrophic Akt. Fibrosis proliferation in the GK LV paralleled increased transcriptional and biologically active pro-fibrogenic transforming growth factor-β1 (TGFβ1) in the LV with upregulated mRNA abundance for key extracellular matrix (ECM) components such as fibronectin, collagen type(s) 1 and 3α and regulators including matrix metalloproteinases 2 and 9, and their tissue inhibitor (TIMP) 4, connexin 43 and α5-integrin. GK rats also presented with altered mRNA expression for cardiac sarcoplasmic reticulum Ca(2+)ATPase, Na(+)/Ca(2+) exchanger and the L-type Ca(2+) channels which may contribute to the altered Ca(2+) transient kinetics previously observed in this model at 18 months of age (t test, p < 0.05 vs. age-matched Wistar control for all parameters). The results indicate that chronic mild HG can produce the molecular and structural correlates of a hypertrophic myopathy. Diffuse ECM proliferation in this model is possibly a product of HG-induced TGFβ1 upregulation and altered transcriptional profile of the ECM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23430124     DOI: 10.1007/s10741-013-9376-9

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  34 in total

Review 1.  Cardiac remodeling as a consequence and cause of progressive heart failure.

Authors:  K Kurrelmeyer; D Kalra; B Bozkurt; F Wang; Z Dibbs; Y Seta; G Baumgarten; D Engle; N Sivasubramanian; D L Mann
Journal:  Clin Cardiol       Date:  1998-12       Impact factor: 2.882

2.  Ageing-dependent remodelling of ion channel and Ca2+ clock genes underlying sino-atrial node pacemaking.

Authors:  James O Tellez; Michal Mczewski; Joseph Yanni; Pavel Sutyagin; Urszula Mackiewicz; Andrew Atkinson; Shin Inada; Andrzej Beresewicz; Rudi Billeter; Halina Dobrzynski; M R Boyett
Journal:  Exp Physiol       Date:  2011-07-01       Impact factor: 2.969

3.  Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.

Authors:  Xuemin Wang; Anne Beugnet; Mirei Murakami; Shinya Yamanaka; Christopher G Proud
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

4.  Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes.

Authors:  B Portha; P Serradas; D Bailbé; K Suzuki; Y Goto; M H Giroix
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

5.  Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism.

Authors:  Loren E Wold; Jun Ren
Journal:  Biochem Biophys Res Commun       Date:  2004-06-11       Impact factor: 3.575

6.  B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation.

Authors:  Ann M Kapoun; Faquan Liang; Gilbert O'Young; Deborah L Damm; Diana Quon; R Tyler White; Kimberly Munson; Andrew Lam; George F Schreiner; Andrew A Protter
Journal:  Circ Res       Date:  2004-01-15       Impact factor: 17.367

7.  Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.

Authors:  Julie R McMullen; Tetsuo Shioi; Li Zhang; Oleg Tarnavski; Megan C Sherwood; Adam L Dorfman; Sarah Longnus; Mario Pende; Kathleen A Martin; John Blenis; George Thomas; Seigo Izumo
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

10.  Structural remodelling of the sinoatrial node in obese old rats.

Authors:  J Yanni; J O Tellez; P V Sutyagin; M R Boyett; H Dobrzynski
Journal:  J Mol Cell Cardiol       Date:  2009-09-01       Impact factor: 5.000

View more
  12 in total

1.  Voltage dependence of the Ca2+ transient in endocardial and epicardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats.

Authors:  Lina Al Kury; Vadym Sydorenko; Manal M A Smail; Muhammad Anwar Qureshi; Anatoliy Shmygol; Murat Oz; Jaipaul Singh; Frank Christopher Howarth
Journal:  Mol Cell Biochem       Date:  2018-01-09       Impact factor: 3.396

Review 2.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

Review 3.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.

Authors:  Guanghong Jia; Vincent G DeMarco; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2015-12-18       Impact factor: 43.330

4.  Type 1 diabetes mellitus induces structural changes and molecular remodelling in the rat kidney.

Authors:  Raphael M Singh; Frank C Howarth; Ernest Adeghate; Keshore Bidasee; Jaipaul Singh; Tehreem Waqar
Journal:  Mol Cell Biochem       Date:  2018-02-23       Impact factor: 3.396

Review 5.  Diabetic fibrosis.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-12-28       Impact factor: 5.187

6.  The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats.

Authors:  Márta Sárközy; Gergő Szűcs; Márton Pipicz; Ágnes Zvara; Katalin Éder; Veronika Fekete; Csilla Szűcs; Judit Bárkányi; Csaba Csonka; László G Puskás; Csaba Kónya; Péter Ferdinandy; Tamás Csont
Journal:  Cardiovasc Diabetol       Date:  2015-06-28       Impact factor: 9.951

7.  Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki rats.

Authors:  Márta Sárközy; Gergő Szűcs; Veronika Fekete; Márton Pipicz; Katalin Éder; Renáta Gáspár; Andrea Sója; Judit Pipis; Péter Ferdinandy; Csaba Csonka; Tamás Csont
Journal:  Cardiovasc Diabetol       Date:  2016-08-05       Impact factor: 9.951

Review 8.  Calcium Signaling in the Ventricular Myocardium of the Goto-Kakizaki Type 2 Diabetic Rat.

Authors:  L Al Kury; M Smail; M A Qureshi; V Sydorenko; A Shmygol; M Oz; J Singh; F C Howarth
Journal:  J Diabetes Res       Date:  2018-04-10       Impact factor: 4.011

9.  The Pattern of mRNA Expression Is Changed in Sinoatrial Node from Goto-Kakizaki Type 2 Diabetic Rat Heart.

Authors:  F C Howarth; M A Qureshi; P Jayaprakash; K Parekh; M Oz; H Dobrzynski; T E Adrian
Journal:  J Diabetes Res       Date:  2018-09-02       Impact factor: 4.011

10.  Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction.

Authors:  Bo Bai; Wulin Yang; Yanyun Fu; Hannah Lee Foon; Wan Ting Tay; Kangmin Yang; Cuiting Luo; Jayantha Gunaratne; Philip Lee; Michael R Zile; Aimin Xu; Calvin W L Chin; Carolyn S P Lam; Weiping Han; Yu Wang
Journal:  JACC Basic Transl Sci       Date:  2019-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.